Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Obstruction: 5-year Outcomes of a Randomised, Open-label, Noninferiority Trial.

Publication

Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Obstruction: 5-year Outcomes of a Randomised, Open-label, Noninferiority Trial.

Journal Paper/Review - Mar 25, 2024

Muellhaupt Gautier, Hechelhammer Lukas, Graf Nicole, Mordasini Livio, Schmid Hans-Peter, Engeler Daniel, Abt Dominik

Citation

Muellhaupt G, Hechelhammer L, Graf N, Mordasini L, Schmid H, Engeler D, Abt D. Prostatic Artery Embolisation Versus Transurethral Resection of the Prostate for Benign Prostatic Obstruction: 5-year Outcomes of a Randomised, Open-label, Noninferiority Trial. Eur Urol Focus 2024; 10:788-795.

Type

Journal Paper/Review (English)

Journal

Eur Urol Focus 2024; 10

Publication Date

Mar 25, 2024

Issn Electronic

2405-4569

Pages

788-795

Brief description/objective

Prostatic artery embolisation (PAE) and transurethral resection of the prostate (TURP) are two of the surgical options for treatment of lower urinary tract symptoms/benign prostatic obstruction (LUTS/BPO). Our aim was to compare the efficacy and safety of PAE and TURP for LUTS/BPO treatment at long-term follow-up.